Luis Masmiquel

Palma, PM 07122, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

ADORA2B/ador-1 is required for multi-system transcriptional adaptation to mild hypoxia and healthspan extension in C. elegans.

ADORA2B/ador-1 is required for multi-system transcriptional adaptation to mild hypoxia and healthspan extension in C. elegans.

Journal: Free radical biology & medicine

Published: March 27, 2026

GDF-15 as a proxy for epigenetic aging: associations with biological age markers, and physical function.

GDF-15 as a proxy for epigenetic aging: associations with biological age markers, and physical function.

Journal: Biogerontology

Published: October 17, 2024

Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women.

Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women.

Journal: International journal of molecular sciences

Published: July 17, 2023

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study.

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study.

Journal: European thyroid journal

Published: March 03, 2023

Phytate Intake, Health and Disease: "Let Thy Food Be Thy Medicine and Medicine Be Thy Food".

Phytate Intake, Health and Disease: "Let Thy Food Be Thy Medicine and Medicine Be Thy Food".

Journal: Antioxidants (Basel, Switzerland)

Published: December 07, 2022

GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility.

GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility.

Journal: Frontiers in cellular and infection microbiology

Published: May 13, 2022

Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial.

Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial.

Journal: Nutrition & diabetes

Published: March 29, 2022

Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids.

Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids.

Journal: International journal of molecular sciences

Published: September 08, 2021

Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.

Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.

Journal: Journal of endocrinological investigation

Published: August 11, 2021

Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus.

Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus.

Journal: Journal of clinical medicine

Published: May 19, 2020

Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.

Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.

Journal: Scientific reports

Published: March 23, 2018

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.

Journal: The lancet. Diabetes & endocrinology

Published: January 15, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026